 | • レポートコード：MRC23Q36443 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、81ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の静脈逆流症治療市場について調査・分析し、世界の静脈逆流症治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（手術治療、非外科的治療）、用途別セグメント分析（病院、外来手術センター、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、SIGVARIS、PROTEOR、Bauerfeind、Ofa Bamberg GmbH、Lincoln Pharmaceuticals Ltd.、Zydus Cadila Healthcare Ltd.、Twilight Mercantile Pvt. Ltd.、Comed Chemicals Ltd.などが含まれています。世界の静脈逆流症治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、静脈逆流症治療市場規模を推定する際に考慮しました。本レポートは、静脈逆流症治療の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、静脈逆流症治療に関するビジネス上の意思決定に役立てることを目的としています。 ・静脈逆流症治療市場の概要 - 静脈逆流症治療のタイプ別セグメント - 世界の静脈逆流症治療市場規模：タイプ別分析（手術治療、非外科的治療） - 静脈逆流症治療の用途別セグメント - 世界の静脈逆流症治療市場規模：用途別分析（病院、外来手術センター、その他） - 世界の静脈逆流症治療市場規模予測（2018年-2029年） ・静脈逆流症治療市場の成長トレンド - 静脈逆流症治療の地域別市場規模（2018年-2029年） - 静脈逆流症治療市場ダイナミクス - 静脈逆流症治療の業界動向 - 静脈逆流症治療市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：手術治療、非外科的治療 - 世界の静脈逆流症治療のタイプ別市場規模（2018年-2023年） - 世界の静脈逆流症治療のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、外来手術センター、その他 - 世界の静脈逆流症治療の用途別市場規模（2018年-2023年） - 世界の静脈逆流症治療の用途別市場規模（2024年-2029年） ・静脈逆流症治療の地域別市場規模 - 北米の静脈逆流症治療市場規模（2018年-2029年） - アメリカの静脈逆流症治療市場規模（2018年-2029年） - ヨーロッパの静脈逆流症治療市場規模（2018年-2029年） - アジア太平洋の静脈逆流症治療市場規模（2018年-2029年） - 中国の静脈逆流症治療市場規模（2018年-2029年） - 日本の静脈逆流症治療市場規模（2018年-2029年） - 韓国の静脈逆流症治療市場規模（2018年-2029年） - インドの静脈逆流症治療市場規模（2018年-2029年） - オーストラリアの静脈逆流症治療市場規模（2018年-2029年） - 中南米の静脈逆流症治療市場規模（2018年-2029年） - 中東・アフリカの静脈逆流症治療市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 SIGVARIS、PROTEOR、Bauerfeind、Ofa Bamberg GmbH、Lincoln Pharmaceuticals Ltd.、Zydus Cadila Healthcare Ltd.、Twilight Mercantile Pvt. Ltd.、Comed Chemicals Ltd. ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Venous Reflux Disease Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Venous Reflux Disease Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Venous Reflux Disease Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Venous Reflux Disease Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Venous Reflux Disease Treatment include SIGVARIS, PROTEOR, Bauerfeind, Ofa Bamberg GmbH, Lincoln Pharmaceuticals Ltd., Zydus Cadila Healthcare Ltd., Twilight Mercantile Pvt. Ltd. and Comed Chemicals Ltd., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Venous Reflux Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venous Reflux Disease Treatment.
The Venous Reflux Disease Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Venous Reflux Disease Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Venous Reflux Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
SIGVARIS
PROTEOR
Bauerfeind
Ofa Bamberg GmbH
Lincoln Pharmaceuticals Ltd.
Zydus Cadila Healthcare Ltd.
Twilight Mercantile Pvt. Ltd.
Comed Chemicals Ltd.
Segment by Type
Operation Treatment
Non-Surgical Treatment
Segment by Application
Hospital
Ambulatory Surgery Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Venous Reflux Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Venous Reflux Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Operation Treatment
1.2.3 Non-Surgical Treatment
1.3 Market by Application
1.3.1 Global Venous Reflux Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Venous Reflux Disease Treatment Market Perspective (2018-2029)
2.2 Venous Reflux Disease Treatment Growth Trends by Region
2.2.1 Global Venous Reflux Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Venous Reflux Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Venous Reflux Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Venous Reflux Disease Treatment Market Dynamics
2.3.1 Venous Reflux Disease Treatment Industry Trends
2.3.2 Venous Reflux Disease Treatment Market Drivers
2.3.3 Venous Reflux Disease Treatment Market Challenges
2.3.4 Venous Reflux Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Venous Reflux Disease Treatment Players by Revenue
3.1.1 Global Top Venous Reflux Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Venous Reflux Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Venous Reflux Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Venous Reflux Disease Treatment Revenue
3.4 Global Venous Reflux Disease Treatment Market Concentration Ratio
3.4.1 Global Venous Reflux Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Venous Reflux Disease Treatment Revenue in 2022
3.5 Venous Reflux Disease Treatment Key Players Head office and Area Served
3.6 Key Players Venous Reflux Disease Treatment Product Solution and Service
3.7 Date of Enter into Venous Reflux Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Venous Reflux Disease Treatment Breakdown Data by Type
4.1 Global Venous Reflux Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Venous Reflux Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Venous Reflux Disease Treatment Breakdown Data by Application
5.1 Global Venous Reflux Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Venous Reflux Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Venous Reflux Disease Treatment Market Size (2018-2029)
6.2 North America Venous Reflux Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Venous Reflux Disease Treatment Market Size by Country (2018-2023)
6.4 North America Venous Reflux Disease Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Venous Reflux Disease Treatment Market Size (2018-2029)
7.2 Europe Venous Reflux Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Venous Reflux Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Venous Reflux Disease Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Venous Reflux Disease Treatment Market Size (2018-2029)
8.2 Asia-Pacific Venous Reflux Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Venous Reflux Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Venous Reflux Disease Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Venous Reflux Disease Treatment Market Size (2018-2029)
9.2 Latin America Venous Reflux Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Venous Reflux Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Venous Reflux Disease Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Venous Reflux Disease Treatment Market Size (2018-2029)
10.2 Middle East & Africa Venous Reflux Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Venous Reflux Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Venous Reflux Disease Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SIGVARIS
11.1.1 SIGVARIS Company Detail
11.1.2 SIGVARIS Business Overview
11.1.3 SIGVARIS Venous Reflux Disease Treatment Introduction
11.1.4 SIGVARIS Revenue in Venous Reflux Disease Treatment Business (2018-2023)
11.1.5 SIGVARIS Recent Development
11.2 PROTEOR
11.2.1 PROTEOR Company Detail
11.2.2 PROTEOR Business Overview
11.2.3 PROTEOR Venous Reflux Disease Treatment Introduction
11.2.4 PROTEOR Revenue in Venous Reflux Disease Treatment Business (2018-2023)
11.2.5 PROTEOR Recent Development
11.3 Bauerfeind
11.3.1 Bauerfeind Company Detail
11.3.2 Bauerfeind Business Overview
11.3.3 Bauerfeind Venous Reflux Disease Treatment Introduction
11.3.4 Bauerfeind Revenue in Venous Reflux Disease Treatment Business (2018-2023)
11.3.5 Bauerfeind Recent Development
11.4 Ofa Bamberg GmbH
11.4.1 Ofa Bamberg GmbH Company Detail
11.4.2 Ofa Bamberg GmbH Business Overview
11.4.3 Ofa Bamberg GmbH Venous Reflux Disease Treatment Introduction
11.4.4 Ofa Bamberg GmbH Revenue in Venous Reflux Disease Treatment Business (2018-2023)
11.4.5 Ofa Bamberg GmbH Recent Development
11.5 Lincoln Pharmaceuticals Ltd.
11.5.1 Lincoln Pharmaceuticals Ltd. Company Detail
11.5.2 Lincoln Pharmaceuticals Ltd. Business Overview
11.5.3 Lincoln Pharmaceuticals Ltd. Venous Reflux Disease Treatment Introduction
11.5.4 Lincoln Pharmaceuticals Ltd. Revenue in Venous Reflux Disease Treatment Business (2018-2023)
11.5.5 Lincoln Pharmaceuticals Ltd. Recent Development
11.6 Zydus Cadila Healthcare Ltd.
11.6.1 Zydus Cadila Healthcare Ltd. Company Detail
11.6.2 Zydus Cadila Healthcare Ltd. Business Overview
11.6.3 Zydus Cadila Healthcare Ltd. Venous Reflux Disease Treatment Introduction
11.6.4 Zydus Cadila Healthcare Ltd. Revenue in Venous Reflux Disease Treatment Business (2018-2023)
11.6.5 Zydus Cadila Healthcare Ltd. Recent Development
11.7 Twilight Mercantile Pvt. Ltd.
11.7.1 Twilight Mercantile Pvt. Ltd. Company Detail
11.7.2 Twilight Mercantile Pvt. Ltd. Business Overview
11.7.3 Twilight Mercantile Pvt. Ltd. Venous Reflux Disease Treatment Introduction
11.7.4 Twilight Mercantile Pvt. Ltd. Revenue in Venous Reflux Disease Treatment Business (2018-2023)
11.7.5 Twilight Mercantile Pvt. Ltd. Recent Development
11.8 Comed Chemicals Ltd.
11.8.1 Comed Chemicals Ltd. Company Detail
11.8.2 Comed Chemicals Ltd. Business Overview
11.8.3 Comed Chemicals Ltd. Venous Reflux Disease Treatment Introduction
11.8.4 Comed Chemicals Ltd. Revenue in Venous Reflux Disease Treatment Business (2018-2023)
11.8.5 Comed Chemicals Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
